Skip to main content
    A

    Alpha Teknova Inc (TKNO)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $7.81
    -0.07 (-0.89%)

    Market Cap: $454.75M

    Last updated: Nov 06, 2026 at 4:10 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    83%(19/23)
    Avg Surprise
    +3.33%
    Streak
    8 Q

    Upcoming Estimates

    Period ending Dec 31, 2026
    EPS Consensus$-0.06
    Range$-0.08 - $-0.05
    4 analysts
    Revenue Consensus
    $13M
    Range$12M - $13M
    8 analysts
    Last 12 of 25 reported quarters and 1 upcoming estimate
    PeriodReportedEst.RangeSurpriseB/MAnalystsRevisionsYoY
    Dec 26EST
    		-$-0.06$-0.08 - $-0.05--4--
    Sep 26
    Reported Nov 4
    		$-0.06$-0.06$-0.06 - $-0.06+0.00%Beat4
    4
    1
    30d
    		+25.0%
    Jun 26
    Reported Aug 5
    		$-0.06$-0.08$-0.08 - $-0.08+25.00%Beat1
    No revisions (30d)
    		+14.3%
    Mar 26
    Reported May 6
    		$-0.08$-0.09$-0.10 - $-0.09+11.11%Beat3
    1
    2
    30d
    		+11.1%
    Dec 25
    Reported Feb 26
    		$-0.09$-0.09$-0.10 - $-0.08+0.00%Beat5
    0
    1
    30d
    		+18.2%
    Sep 25
    Reported Nov 6
    		$-0.08$-0.09$-0.10 - $-0.08+11.11%Beat4
    1
    0
    30d
    		+46.7%
    Jun 25
    Reported Aug 7
    		$-0.07$-0.10$-0.10 - $-0.10+29.72%Beat1
    No revisions (30d)
    		+46.2%
    Mar 25
    Reported May 8
    		$-0.09$-0.11$-0.11 - $-0.11+18.18%Beat0
    No revisions (30d)
    		+55.0%
    Dec 24
    Reported Mar 4
    		$-0.11$-0.12$-0.13 - $-0.11+8.33%Beat4
    1
    0
    30d
    		+47.6%
    Sep 24
    Reported Nov 7
    		$-0.15$-0.11$-0.14 - $-0.10-36.36%Miss4
    No revisions (30d)
    		+42.3%
    Jun 24
    Reported Aug 13
    		$-0.13$-0.16$-0.17 - $-0.15+18.75%Beat4
    1
    0
    30d
    		+27.8%
    Mar 24
    Reported May 13
    		$-0.20$-0.25$-0.29 - $-0.22+20.00%Beat4
    No revisions (30d)
    		+35.5%
    Dec 23
    Reported Mar 11
    		$-0.21$-0.24$-0.32 - $-0.20+12.50%Beat4
    No revisions (30d)
    		+55.3%

    Key Metrics

    Valuation
    P/E Ratio-26.93EV/EBITDAN/A
    Price/FCF-65.69xFCF Yield-1.52%
    Profitability
    Profit Margin-38.40%Operating Margin-23.70%
    ROE-24.20%ROIC-20.52%
    Financial Health
    Debt/Equity0.22xInterest Coverage-15.93x
    Current Ratio3.56xQuick Ratio2.72x
    Trading Statistics
    Beta0.96Avg Volume756.37K
    52-Week High$9.4852-Week Low$1.91

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$7.44
    SMA 20$7.32
    SMA 50$7.73
    SMA 200$4.99
    EMA 10$7.48
    EMA 20$7.51
    EMA 50$7.43
    EMA 200$5.92

    MACD

    Line: -0.07Signal: -0.16Hist: 0.09

    ADX

    ADX: 18.0+DI: 30.6-DI: 22.6

    Aroon & PSAR

    Aroon Up8.0
    Aroon Down52.0
    PSAR$6.39

    Bollinger Bands

    Upper Band$8.76
    Lower Band$5.88
    %B Position3924%(Upper)
    Band Width0.67

    RSI (14-Day)

    Neutral
    52.9

    Momentum Oscillators

    Stoch %K82.0
    Stoch %D77.4
    Williams %R-19.6
    ROC (10d)21.7%
    Momentum1.39
    CCI (20d)81.2
    MFI (14d)57.6

    Volatility Measures

    ATR (14d)$0.67(8.6%)
    StdDev (20d)0.72
    Hist Vol117.8%(High)

    Volume Flow

    VWAP$8.00
    OBV-6.6M
    AD Line9.3M
    CMF (20d)0.392

    Volume Metrics

    Avg Vol (20d)809.6K
    Vol Ratio0.7x
    VWMA (20d)$6.76

    Pivot Points

    R3$8.96
    R2$8.49
    R1$8.19
    Pivot Point$7.72
    S1$7.42
    S2$6.95
    S3$6.65

    Advanced Oscillators

    TSI-3.23
    Ultimate Osc49.4
    KST-87.42

    Financial Data

    QuarterSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total Revenue$12.70M$12.19M$11.08M$9.98M$10.45M$10.29M$9.79M$9.27M$9.58M$9.61M$9.29M$7.87M
    Cost of Revenue$7.88M$7.30M$7.29M$6.74M$7.25M$6.30M$6.79M$7.14M$9.49M$6.81M$7.08M$6.53M
    Gross Profit$4.83M$4.88M$3.78M$3.24M$3.21M$3.98M$3.01M$2.13M$90,000$2.80M$2.21M$1.33M
    Operating Expenses$8.03M$7.78M$8.08M$7.85M$7.22M$7.37M$7.97M$7.76M$7.52M$7.90M$10.20M$12.19M
    R&D$581,000$554,000$609,000$522,000$542,000$581,000$552,000$594,000$627,000$678,000$860,000$1.31M
    SG&A$4.82M$4.81M$5.06M$5.25M$4.65M$4.93M$5.49M$5.32M$4.97M$5.48M$7.38M$6.02M
    Operating Income$-3,206,000$-2,890,000$-4,298,000$-4,609,000$-4,017,000$-3,386,000$-4,964,000$-5,628,000$-7,432,000$-5,100,000$-7,986,000$-10,858,000
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$259,000$252,000$219,000$211,000$190,000$165,000$144,000$129,000$141,000$272,000$145,000$-173,000
    Income Before Tax$-3,456,000$-3,140,000$-4,508,000$-4,820,000$-4,207,000$-3,551,000$-4,623,000$-5,757,000$-7,573,000$-5,372,000$-8,131,000$-10,960,000
    Income Tax Expense$34,000$30,000$47,000$-62,000$79,000$19,000$22,000$-38,000$-8,000$-8,000$-34,000$-304,000
    Net Income$-3,490,000$-3,170,000$-4,555,000$-4,758,000$-4,286,000$-3,570,000$-4,645,000$-5,719,000$-7,565,000$-5,364,000$-8,097,000$-10,656,000
    EBITDA$-1,649,000$-1,305,000$-2,762,000$-3,087,000$-2,535,000$-1,924,000$-2,997,000$-4,224,000$-5,658,000$-3,370,000$-6,266,000$-9,439,000
    EBIT$-3,197,000$-2,888,000$-4,298,000$-4,609,000$-4,017,000$-3,386,000$-4,479,000$-5,628,000$-7,432,000$-5,100,000$-7,986,000$-11,133,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about TKNO

    TKNO Valuation and Fair Value

    P/E
    -26.9x
    P/FCF
    -65.7x
    P/B
    7.0x
    See GNG's fair value

    TKNO Profitability: Margins, ROIC and FCF

    Gross margin
    36.4%
    Operating margin
    -23.7%
    Net margin
    -38.4%
    ROIC
    -20.5%
    ROE
    -24.2%
    FCF margin
    -13.9%
    FCF yield
    -1.5%

    TKNO Competitors

    CompanyTicker
    Neuropace IncNPCE
    Evolus IncEOLS
    Strata Critical Medical, Inc.SRTA
    ProKidney Corp.PROK
    Senseonics Holdings, Inc. Common StockSENS
    Indaptus Therapeutics IncINDP
    XOMA CorpXOMA
    XOMA CorporationXOMAO

    Sector: Healthcare

    TKNO Analyst Ratings

    Consensus
    Buy
    Analysts
    8
    Strong Buy
    0
    Buy
    7
    Hold
    1
    Sell
    0
    Strong Sell
    0

    TKNO Bull Case vs Bear Case

    Bull case

    • TKNO beat EPS estimates in 75.0% of its last 8 reported quarters.
    • TKNO grew quarterly revenue 18.5% year over year.
    • 87.5% of TKNO's analyst ratings are Buy or Strong Buy.

    Bear case

    • TKNO has a -38.4% net profit margin.

    TKNO Earnings: Beat Rate and Next Report

    Beat rate
    6 of 8 quarters (75.0%)
    Average surprise
    12.9%
    EPS estimate (fiscal period ending Dec 31, 2026)
    $-0.06

    TKNO Earnings Date

    TKNO reports Feb 24, 2027, after the close. The date is estimated.

    TKNO Earnings Call

    The latest TKNO earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    TKNO ETF Holders

    GNG tracks 6 ETFs that hold TKNO. The largest weights:

    1. iShares Biotechnology ETF (IBB), 0.01% of the fund
    2. Vanguard Total Stock Market Index Fund Admiral Shares (VTSAX), <0.01% of the fund
    3. iShares Russell 2000 ETF (IWM), <0.01% of the fund
    4. Vanguard Morningstar Total Stock Market ETF (VTI), <0.01% of the fund
    5. Vanguard Russell 2000 Index Fund ETF Shares (VTWO), <0.01% of the fund
    Open the ETF Stock Exposure tool for TKNO

    See insider activity

    Frequently Asked Questions About TKNO

    When does TKNO report earnings?

    Alpha Teknova Inc (TKNO) is expected to report earnings on Feb 24, 2027.

    Does TKNO pay dividends?

    Alpha Teknova Inc (TKNO) does not currently pay a regular dividend.

    What is TKNO's market cap?

    Alpha Teknova Inc (TKNO) has a market capitalization of $454.75M with a current stock price of $7.81.

    Related stocks

    Sector: Healthcare

    All stocks starting with T

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In